DKK1 and neoplasm: <b>Conclusions:</b> We demonstrate that DKK1 is an epithelial-derived regulator linked to malignant progression and tumor-stroma-immune remodeling, supporting its potential as a biomarker and therapeutic target in PDAC treatment, including rational combinations with stroma-modulating strategies and immunotherapy.